Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Migraine

  Free Subscription


16.09.2019

1 Cephalalgia
5 Headache
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cephalalgia

  1. DIENER HC, Goadsby PJ, Ashina M, Al-Karagholi MA, et al
    Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Cephalalgia. 2019 Sep 15:333102419876920. doi: 10.1177/0333102419876920.
    PubMed     Text format     Abstract available


    Headache

  2. MASTERS-ISRAILOV A, Robbins MS
    OnabotulinumtoxinA Wear-off Phenomenon in the Treatment of Chronic Migraine.
    Headache. 2019 Sep 16. doi: 10.1111/head.13638.
    PubMed     Text format     Abstract available

  3. HAMMOND NG, Orr SL, Colman I
    Early Life Stress in Adolescent Migraine and the Mediational Influence of Symptoms of Depression and Anxiety in a Canadian Cohort.
    Headache. 2019 Sep 16. doi: 10.1111/head.13644.
    PubMed     Text format     Abstract available

  4. BARBANTI P, Egeo G, Mitsikostas DD
    Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?
    Headache. 2019 Sep 11. doi: 10.1111/head.13635.
    PubMed     Text format     Abstract available

  5. VANDERPLUYM JH, Hamilton K, Hindiyeh NA, Robbins MS, et al
    Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.
    Headache. 2019 Sep 11. doi: 10.1111/head.13649.
    PubMed     Text format    

  6. CHING J, Tinsley A, Rothrock J
    Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.
    Headache. 2019 Sep 9. doi: 10.1111/head.13630.
    PubMed     Text format     Abstract available


    PLoS One

  7. YEO JH, Choi EJ, Lee J
    Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine.
    PLoS One. 2019;14:e0222326.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: